Gilead Sciences Inc (NASDAQ: GILD )
Gilead Sciences Inc Income Statement Quarterly
GILD
Select the Financial Report:
Period:
INCOME STATEMENTGAAP In millions $) (Sep 30 2025)
(Jun 30 2025)
(Mar 31 2025)
(Dec 31 2024)
(Sep 30 2024)
Revenue From Contract With Customer Excluding Assessed Tax
7,769.00 7,082.00 6,667.00 7,545.00
Royalty Contract and Other Revenue
- - - -
Total Revenue 7,769.00 7,082.00 6,667.00 7,569.00 7,545.00
Cost of Goods and Services Sold
1,569.00 1,501.00 1,540.00 1,581.00 1,574.00
Gross
Profit 6,200.00 5,581.00 5,127.00 5,988.00 5,971.00
Selling, Administration, Marketing
1,357.00 1,365.00 1,258.00 1,906.00 1,433.00
Depriciation & Amortization
- - - - -
Research & development
1,346.00 1,491.00 1,379.00 1,641.00 1,395.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
- 190.00 - - 1,750.00
Other operatinig exp. /-income
-86.00 -193.00 -7.00 -513.00 267.00
Special items
- - - - -
Interest Expense Nonoperating
256.00 254.00 260.00 502.00 238.00
Total operating costs including COS
4,442.00 4,608.00 4,430.00 5,117.00 6,657.00
Operating income /-loss 3,327.00 2,474.00 2,237.00 2,452.00 888.00
Other Deductions / - Income
Interest expense
- - - 254.00 -
Interest income
- - - - -
Net interest expense/-income - - - 254.00 -
Loss/ -Gain on Investment
- - - - -
Income from affiliates
- - - - -
Sale of Assets
- - - - -
Financing Loss/ -Income
- - - - -
Other loss/ -income
-314.00 45.00 588.00 31.00 -68.00
Total costs & expenses
4,128.00 4,653.00 5,018.00 5,402.00 6,589.00
Income /-loss before income taxes 3,641.00 2,429.00 1,649.00 2,167.00 956.00
Income taxes expenses/-benefit 589.00 468.00 334.00 385.00 -297.00
Income after income taxes 3,052.00 1,960.00 1,315.00 1,783.00 1,253.00
Net income/-loss
of other equity
- -1.00 - 1.00 -
Income/-loss
from cont. Ops. 3,052.00 1,960.00 1,315.00 1,783.00 1,253.00
Accounting change
- - - - -
Discontinued operations
- - - - -
Extraordinary items
- - - - -
Net Income/-loss 3,052.00 1,960.00 1,315.00 1,783.00 1,253.00
Non-controlling interests
- - - - -
Preferred dividends
- - - - -
Other
- - - - -
Income/-loss to shareholder 3,052.00 1,960.00 1,315.00 1,783.00 1,253.00
EBIT
3,641.00 2,429.00 1,649.00 2,421.00 956.00
EBITD
3,731.00 2,522.00 1,746.00 2,516.00 1,050.00
EBITDA
4,327.00 3,120.00 2,345.00 3,114.00 1,646.00
Per
Share (GAAP Quarterly, in $)
(Sep 30 2025)
(Jun 30 2025)
(Mar 31 2025)
(Dec 31 2024)
(Sep 30 2024)
Basic EPS (excl. extra
items) 2.46 1.57 1.06 1.43 1.00
Extraordinary items
0.00 0.00 0.00 0.00 0.00
Basic Net EPS 2.46 1.57 1.06 1.43 1.00
Basic shares outstanding (Mill.
of Units)
1,243.00 1,245.00 1,246.00 1,247.00 1,247.00
EPS other shares
- - - - -
Diluted Net EPS 2.43 1.56 1.04 1.41 1.00
Diluted average shares (Mill.
of Units)
1,254.00 1,255.00 1,259.00 1,263.16 1,254.00
Dividend per share 0.801 0.792 0.802 0.77 0.784
